Apoptosis signaling by death receptors
Death receptors have been recently identified as a subgroup of the TNF‐receptor superfamily with a predominant function in induction of apoptosis. The receptors are characterized by an intracellular region, called the death domain, which is required for the transmission of the cytotoxic signal. Curr...
Saved in:
Published in: | European journal of biochemistry Vol. 254; no. 3; pp. 439 - 459 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin & Heidelberg
Springer‐Verlag
15-06-1998
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Death receptors have been recently identified as a subgroup of the TNF‐receptor superfamily with a predominant function in induction of apoptosis. The receptors are characterized by an intracellular region, called the death domain, which is required for the transmission of the cytotoxic signal. Currently, five different such death receptors are known including tumor necrosis factor (TNF) receptor‐1, CD95 (Fas/APO‐1), TNF‐receptor‐related apoptosis‐mediated protein (TRAMP) and TNF‐related apoptosis‐inducing ligand (TRAIL) receptor‐1 and ‐2. The signaling pathways by which these receptors induce apoptosis are rather similar. Ligand binding induces receptor oligomerization, followed by the recruitment of an adaptor protein to the death domain through homophilic interaction. The adaptor protein then binds a proximal caspase, thereby connecting receptor signaling to the apoptotic effector machinery. In addition, further pathways have been linked to death receptor‐mediated apoptosis, such as sphingomyelinases, JNK kinases and oxidative stress. These pro‐apoptotic signals are counteracted by several mechanisms which inhibit apoptosis at different levels. This review summarizes the current and rapidly expanding knowledge about the biological functions of death receptors and the mechanisms to trigger or to counteract cell death. |
---|---|
Bibliography: | E‐mail 49 7071 29 5865. EJB Reviews 1998 AICD, activation‐induced cell death; Apaf, apoptotic protease‐activating factor; CAD, caspase‐activated DNase; CARD, caspase recruitment domain; CD95L, CD95 ligand; CrmA, cytokine response modifier A; DcR, decoy receptor; DD, death domain; DED, death effector domain; DR, death receptor; DISC, death‐inducing signaling complex; FADD, Fas‐associated death domain protein; FAN, factor‐associated neutral sphingomyelinase; FAP; Fas‐associated phosphatase; FLICE, FADD‐like ICE; FLIP, FLICE‐inhibitory protein; IAP, inhibitor of apoptosis protein; ICE, interleukin‐1β‐converting enzyme; JNK, c‐Jun N‐terminal kinase; LT, lymphotoxin; MADD, mitogen‐activated kinase activating death domain protein; MAP, mitogen‐activated protein; mTNF, membrane‐bound TNF; NF‐κB, nuclear factor‐kappa B; PAK, p21‐activated kinase; PARP, poly(ADP‐ribose) polymerase; RAIDD, RIP‐associated ICH‐1/Ced‐3 homologous death domain protein; RIP, receptor‐interacting protein; SAPK, stress‐activated protein kinase; SMase, sphingomyelinase; sTNF, soluble TNF; TNF, tumor necrosis factor; TNF‐R, TNF receptor; TRADD, TNF receptor‐associated death domain protein; TRAF, TNF receptor‐associated factor; TRAIL, TNF‐related apoptosis‐inducing ligand; TRAMP, TNF receptor‐related apoptosis‐mediating protein. Note. K. Schulze‐Osthoff, Department of Internal Medicine I, Medical Clinics, Eberhard‐Karls‐University, Otfried‐Müller‐Str. 10, D‐72076 Tübingen, Germany Abbreviations. Correspondence to This Review will be reprinted in which will be available in April 1999. Fax schulze‐osthoff@uni‐tuebingen.de ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Feature-3 ObjectType-Review-1 |
ISSN: | 0014-2956 1432-1033 1432-1033 |
DOI: | 10.1046/j.1432-1327.1998.2540439.x |